In Vivo Enzyme Inhibition Improves the Targeting of [177Lu]DOTA-GRP(13–27) in GRPR-Positive Tumors in Mice-Reference-Cited by-同舟云学术

In Vivo Enzyme Inhibition Improves the Targeting of [177Lu]DOTA-GRP(13–27) in GRPR-Positive Tumors in Mice

Published:2014-11 Issue:9 Volume:29 Page:359-367
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Marsouvanidis Panteleimon J.¹²,Melis Marleen²,de Blois Erik²,Breeman Wout A.P.²,Krenning Eric P.²,Maina Theodosia¹,Nock Berthold A.¹,de Jong Marion²³

Affiliation:

1. Molecular Radiopharmacy, INRASTES, NSCR Demokritos, Athens, Greece.

2. Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.

3. Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2014.1706

Reference47 articles.

1. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

2. Radiopharmaceutical development of radiolabelled peptides

3. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

4. Design, Synthesis, and Biological Evaluation of Somatostatin-Based Radiopeptides

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties;Current Medicinal Chemistry;2020-12-08

3. Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu‐DOTAGA‐PEG 2 ‐RM26;International Journal of Cancer;2019-05-23

4. Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses;Pharmaceuticals;2019-03-20

5. In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer;Molecular Imaging and Biology;2018-03-19